# A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period

> **NCT03261037** · NA · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 178 (actual)

## Conditions studied

- Idiopathic Pulmonary Fibrosis
- Interstitial Lung Disease

## Interventions

- **OTHER:** Spirometry
- **OTHER:** Accelerometry
- **OTHER:** 6MWT

## Key facts

- **NCT ID:** NCT03261037
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-25
- **Primary completion:** 2019-11-27
- **Final completion:** 2019-11-27
- **Target enrollment:** 178 (ACTUAL)
- **Last updated:** 2021-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03261037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03261037, "A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03261037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*